Abstract
Cirrhosis is the leading cause of portal hypertension in the Western world. From a clinical standpoint, the most significant consequence of portal hypertension is the development of esophageal varices. Despite the many advances in the management of variceal bleeding, it remains a life-threatening complication of portal hypertension. Primary prophylaxis to prevent the first bleeding episode in patients with cirrhosis and esophageal varices is therefore critically important in the management of patients with cirrhosis.
Original language | English |
---|---|
Pages (from-to) | 231-250 |
Number of pages | 20 |
Journal | Clinics in Liver Disease |
Volume | 14 |
Issue number | 2 |
DOIs | |
Publication status | Published - May 2010 |
Bibliographical note
Funding Information:This work was supported by grants from the Spanish Ministry of Education (no. BFU 2006-09280/BFI ), the Fundación Mutua Madrileña (no. FundacionMM-2006-001 ), and from the Spanish Ministry of Health, Instituto de Salud Carlos III (PI051871, Ciberehd).
Keywords
- β-blockers
- Cirrhosis
- Endoscopic variceal ligation
- Portal hypertension
ASJC Scopus subject areas
- Hepatology